Retrospective, single center evaluation of transperineal prostate biopsy omitting antibiotic prophylaxis and omitting periinterventional screening for bacteriuria - Scorecard - MDSpire

Retrospective, single center evaluation of transperineal prostate biopsy omitting antibiotic prophylaxis and omitting periinterventional screening for bacteriuria

  • By

  • Francois Leboutte

  • Tim Schykowski

  • Jeroen Van de Plas

  • Oscar Lemmer

  • Andreas Neisius

  • June 19, 2025

  • 0 min

Share

Clinical Scorecard: Evaluation of Transperineal Prostate Biopsy Without Antibiotic Prophylaxis and Perioperative Bacteriuria Screening: A Single-Center Retrospective Study

At a Glance

CategoryDetail
ConditionProstate cancer suspicion requiring biopsy
Key MechanismsTransperineal prostate biopsy performed without antibiotic prophylaxis or perioperative bacteriuria screening
Target PopulationPatients with suspicion of prostate cancer based on PSA, DRE, or MRI findings
Care SettingOutpatient urology clinic

Key Highlights

  • Transperineal biopsy reduces sepsis risk compared to transrectal approach, potentially allowing omission of antibiotic prophylaxis.
  • Retrospective analysis of 636 patients undergoing transperineal biopsy without antibiotic prophylaxis showed safety regarding infectious complications.
  • Avoiding antibiotic prophylaxis may reduce antibiotic overuse and resistance, addressing a significant public health concern.

Guideline-Based Recommendations

Diagnosis

  • Use transperineal approach for prostate biopsy as recommended by EAU guidelines to reduce infection risk.
  • Perform biopsy based on pathological PSA, DRE, or MRI findings.
  • Exclude patients on anticoagulants (except aspirin) or with contraindications prior to biopsy.

Management

  • Omit antibiotic prophylaxis for transperineal prostate biopsy given low infection risk.
  • Use local anesthesia with periprostatic nerve block; add sedation for MRI fusion biopsies.
  • Perform antiseptic disinfection with 7.5% Povidone-Iodine solution before biopsy.

Monitoring & Follow-up

  • Monitor patients post-procedure for gross hematuria and ability to void before discharge.
  • Collect follow-up data via chart review to identify any infectious or other complications.

Risks

  • Potential infectious complications are low with transperineal biopsy without antibiotics but should be monitored.
  • Selection and follow-up bias may affect retrospective study results.
  • Patients on certain anticoagulants require medication pause prior to biopsy to reduce bleeding risk.

Patient & Prescribing Data

636 patients undergoing transperineal prostate biopsy without antibiotic prophylaxis

Omission of antibiotic prophylaxis did not increase postinterventional infectious complications, supporting safe reduction of antibiotic use.

Clinical Best Practices

  • Adopt transperineal biopsy approach to minimize infectious complications compared to transrectal route.
  • Avoid routine antibiotic prophylaxis in transperineal prostate biopsy to reduce antibiotic resistance risk.
  • Ensure thorough antiseptic skin preparation with Povidone-Iodine before biopsy.
  • Use local anesthesia with periprostatic nerve block; consider sedation for MRI fusion biopsies.
  • Screen patients carefully for contraindications including anticoagulant use and pause medications as needed.
  • Monitor patients post-biopsy for complications before discharge.

References

Original Source(s)

Related Content